The current QGEN market cap is 9.48B. The company's latest EPS is USD 1.4956 and P/E is 27.77.
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 499.49M | 485.4M | 494.86M | 475.89M | 509.16M |
Operating Income | 106.44M | 96.71M | 105.43M | 35.05M | 110.62M |
Net Income | 241.29M | 85.04M | 80.79M | 77.82M | 97.66M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 1.53B | 1.87B | 2.25B | 2.14B | 1.97B |
Operating Income | -47.45M | 383.92M | 635.68M | 533.32M | 409.94M |
Net Income | -69.77M | 73.64M | 537.05M | 575.66M | 341.3M |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 6.35B | 6.28B | 6.35B | 5.91B | 6.12B |
Total Liabilities | 2.96B | 2.72B | 2.72B | 2.21B | 2.31B |
Total Equity | 3.39B | 3.56B | 3.62B | 3.69B | 3.81B |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 5.26B | 5.93B | 6.21B | 6.35B | 6.12B |
Total Liabilities | 2.94B | 3.45B | 3.35B | 2.96B | 2.31B |
Total Equity | 2.32B | 2.48B | 2.86B | 3.39B | 3.81B |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 751.12M | 71.93M | 183.4M | 308.09M | 459.46M |
Investing | -735.58M | -433.85M | -277.57M | -29.2M | -87.66M |
Financing | -152.65M | -9.83M | -25.3M | -426.39M | -433.83M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 367.03M | 492.27M | 675.99M | 751.12M | 459.46M |
Investing | -236.96M | -503.06M | -211.7M | -735.58M | -87.66M |
Financing | -661.75M | -74.32M | -177.8M | -152.65M | -433.83M |
Market Cap | 9.48B |
Price to Earnings Ratio | 27.77 |
Price to Sales Ratio | 4.82 |
Price to Cash Ratio | 14.19 |
Price to Book Ratio | 2.49 |
Dividend Yield | - |
Shares Outstanding | 228.2M |
Average Volume (1 week) | 1.06M |
Average Volume (1 Month) | 903.99k |
52 Week Change | -8.79% |
52 Week High | 49.1739 |
52 Week Low | 35.8135 |
Spread (Intraday) | 0.01 (0.02%) |
Company Name | Qiagen NV |
Address |
hulsterweg 82 venlo, limburg 5912-PL |
Website | https://www.qiagen.com |
Industry | biogenetic (human) (H4) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.